We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prognostic and predictive value of monocarboxylate transporter 4 in patients with breast cancer.
- Authors
Xiao, Sheng; Zhu, Hongjia; Shi, Yujun; Wu, Zhenru; Wu, Hegang; Xie, Mingjun
- Abstract
The Warburg effect explains the large amount of lactic acid that tumour cells produce to establish and maintain the acidic characteristics of the tumour microenvironment, which contributes to the migration, invasion and angiogenesis of tumour cells. Monocarboxylate transporter 4 (MCT-4) is a key marker of tumour glycolysis and lactic acid production; however, the role of MCT-4 in breast cancer remains unclear. In the present study, immunohistochemistry (IHC) was used to detect the expression levels of MCT-4 in tissue microarrays of 145 patients diagnosed with invasive ductal breast cancer. The IHC score was used to assess the intensity of staining and the proportion of positive cells. Western blotting and reverse transcription-quantitative PCR were also performed to detect the expression levels of MCT-4 in 30 pairs of breast cancer tissues and adjacent normal tissues. In vitro experiments (EdU incorporation and Cell Counting Kit-8) were performed to examine the role of MCT-4 in the breast cancer MCF-7 cell line. The results of the present study indicated that high MCT-4 expression was associated with pT status (P=0.018), oestrogen receptor (ER) status (P=0.001), progesterone receptor (PR) status (P=0.024), Ki67 index (P=0.043) and androgen receptor (AR) status (P=0.033). In addition, an association between MCT-4 expression and pathological grade was observed (P=0.030). Furthermore, univariate (P=0.027) and multivariate (P=0.001) survival analysis revealed that MCT-4 expression and lymph node involvement were significant independent predictors of breast cancer prognosis. In addition, silencing MCT-4 expression attenuated breast cancer cell viability. Therefore, MCT-4 may be used as a potential predictor of invasive breast cancer.
- Subjects
MONOCARBOXYLATE transporters; BREAST cancer; BREAST cancer prognosis; CANCER patients; PROGESTERONE receptors
- Publication
Oncology Letters, 2020, Vol 20, Issue 3, p2143
- ISSN
1792-1074
- Publication type
Article
- DOI
10.3892/ol.2020.11776